Research Report Insulin Resistance Epidemiology Clinical Aspects a | Page 3

Companies collaborations for future developments List of Figures are Companies Collaborations vs. Financial year, 2017 Number of Companies Collaborations, 2017 Collaborations and Upfront Deal Values (In million, $), 2017 Number of Products under Development, 2017 Number of Products under Development by Companies, 2017 Number of Products under Development by Indication, 2017 About us: DiligentMarket is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. We support companies by providing end to end comprehensive solutions to improve their performance and in making long lasting decision for their businesses. We advise leading decision makers on their critical issues and opportunities; Research & Development, Strategy Making, Commercial, Operations, Competitive Intelligence, Competitive Landscaping and Mergers & Acquisition across all the Pharma and Biotech industries and geographies. We serve our clients by delivering practical and enduring results, and equipping our clients to grow and lead. The pharmaceuticals market is in its growth stage and we are uniquely positioned to successfully endeavor the dimensions of the fast growing market by providing cutting-edge market and Epidemiology information, to our clients. Connect With us on: [phone] [email protected]